Moreover, genetic testing is crucial in distinguishing FHH from PHPT in cases with mild hypercalcemia and hypocalciuria, as patients with inactivating mutations in CASR, GNA11, or AP2S1 do not benefit from parathyroidectomy (101). Here, CASR is linked to hypercalcemia disease.